{"id":"https://openalex.org/W1978614429","doi":"https://doi.org/10.1097/ajp.0b013e3181fe13f6","title":"Pregabalin for Peripheral Neuropathic Pain: A Multicenter, Enriched Enrollment Randomized Withdrawal Placebo-controlled Trial","display_name":"Pregabalin for Peripheral Neuropathic Pain: A Multicenter, Enriched Enrollment Randomized Withdrawal Placebo-controlled Trial","publication_year":2010,"publication_date":"2010-12-22","ids":{"openalex":"https://openalex.org/W1978614429","doi":"https://doi.org/10.1097/ajp.0b013e3181fe13f6","mag":"1978614429","pmid":"https://pubmed.ncbi.nlm.nih.gov/21178603"},"language":"en","primary_location":{"id":"doi:10.1097/ajp.0b013e3181fe13f6","doi":"https://doi.org/10.1097/ajp.0b013e3181fe13f6","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ajp.0b013e3181fe13f6","pdf_url":null,"source":{"id":"https://openalex.org/S102460418","display_name":"Clinical Journal of Pain","issn_l":"0749-8047","issn":["0749-8047","1536-5409"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Clinical Journal of Pain","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004260153","display_name":"Ian Gilron","orcid":"https://orcid.org/0000-0002-5293-8792","observed_orcids":["https://orcid.org/0000-0002-5293-8792"]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Ian Gilron","raw_affiliation_strings":["Department of Anesthesiology, Queen's University, Kingston, Ontario, Canada. gilroni@post.queensu.ca","Departments of Anesthesiology and Pharmacology and Toxicology, Queen's University, Kingston, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Anesthesiology, Queen's University, Kingston, Ontario, Canada. gilroni@post.queensu.ca","institution_ids":["https://openalex.org/I204722609"]},{"raw_affiliation_string":"Departments of Anesthesiology and Pharmacology and Toxicology, Queen's University, Kingston, Ontario","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025219337","display_name":"Dalia Wajsbrot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210155296","display_name":"Pfizer (Canada)","ror":"https://ror.org/059g90c15","country_code":"CA","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210155296"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Dalia Wajsbrot","raw_affiliation_strings":["Pfizer Global Pharmaceuticals, New York, NY","The study was initiated and funded by Pfizer Canada, Kirkland, Quebec, CA. Ian Gilron received research support and honoraria for consulting and advisory boards for Pfizer Inc and has no other financial interest relevant to this trial. Dalia Wajsbrot, Fran\u00e7ois Therrien, and Jacinthe Lemay are employees of Pfizer. The manuscript was prepared with assistance from Janet Bray, MPharmS and was funded by Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Global Pharmaceuticals, New York, NY","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"The study was initiated and funded by Pfizer Canada, Kirkland, Quebec, CA. Ian Gilron received research support and honoraria for consulting and advisory boards for Pfizer Inc and has no other financial interest relevant to this trial. Dalia Wajsbrot, Fran\u00e7ois Therrien, and Jacinthe Lemay are employees of Pfizer. The manuscript was prepared with assistance from Janet Bray, MPharmS and was funded by Pfizer","institution_ids":["https://openalex.org/I4210155296"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002387457","display_name":"Fran\u00e7ois Therrien","orcid":"https://orcid.org/0000-0002-6512-4333","observed_orcids":["https://orcid.org/0000-0002-6512-4333"]},"institutions":[{"id":"https://openalex.org/I4210155296","display_name":"Pfizer (Canada)","ror":"https://ror.org/059g90c15","country_code":"CA","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210155296"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Therrien","raw_affiliation_strings":["Pfizer Canada Inc, Montreal, Canada","The study was initiated and funded by Pfizer Canada, Kirkland, Quebec, CA. Ian Gilron received research support and honoraria for consulting and advisory boards for Pfizer Inc and has no other financial interest relevant to this trial. Dalia Wajsbrot, Fran\u00e7ois Therrien, and Jacinthe Lemay are employees of Pfizer. The manuscript was prepared with assistance from Janet Bray, MPharmS and was funded by Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Canada Inc, Montreal, Canada","institution_ids":["https://openalex.org/I4210155296"]},{"raw_affiliation_string":"The study was initiated and funded by Pfizer Canada, Kirkland, Quebec, CA. Ian Gilron received research support and honoraria for consulting and advisory boards for Pfizer Inc and has no other financial interest relevant to this trial. Dalia Wajsbrot, Fran\u00e7ois Therrien, and Jacinthe Lemay are employees of Pfizer. The manuscript was prepared with assistance from Janet Bray, MPharmS and was funded by Pfizer","institution_ids":["https://openalex.org/I4210155296"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067169596","display_name":"Jacinthe Lemay","orcid":"https://orcid.org/0000-0002-3558-6318","observed_orcids":["https://orcid.org/0000-0002-3558-6318"]},"institutions":[{"id":"https://openalex.org/I4210155296","display_name":"Pfizer (Canada)","ror":"https://ror.org/059g90c15","country_code":"CA","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210155296"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jacinthe Lemay","raw_affiliation_strings":["Pfizer Canada Inc, Montreal, Canada","The study was initiated and funded by Pfizer Canada, Kirkland, Quebec, CA. Ian Gilron received research support and honoraria for consulting and advisory boards for Pfizer Inc and has no other financial interest relevant to this trial. Dalia Wajsbrot, Fran\u00e7ois Therrien, and Jacinthe Lemay are employees of Pfizer. The manuscript was prepared with assistance from Janet Bray, MPharmS and was funded by Pfizer"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Canada Inc, Montreal, Canada","institution_ids":["https://openalex.org/I4210155296"]},{"raw_affiliation_string":"The study was initiated and funded by Pfizer Canada, Kirkland, Quebec, CA. Ian Gilron received research support and honoraria for consulting and advisory boards for Pfizer Inc and has no other financial interest relevant to this trial. Dalia Wajsbrot, Fran\u00e7ois Therrien, and Jacinthe Lemay are employees of Pfizer. The manuscript was prepared with assistance from Janet Bray, MPharmS and was funded by Pfizer","institution_ids":["https://openalex.org/I4210155296"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5004260153"],"corresponding_institution_ids":["https://openalex.org/I204722609"],"apc_list":null,"apc_paid":null,"fwci":4.2044,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.9404833,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"27","issue":"3","first_page":"185","last_page":"193"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11840","display_name":"Pain Management and Treatment","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":1.0},{"id":"https://openalex.org/keywords/painful-peripheral-neuropathy","display_name":"peripheral neuropathic pain","score":0.9890000224113464},{"id":"https://openalex.org/keywords/diabetic-peripheral-neuropathy","display_name":"diabetic peripheral neuropathy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/postherpetic-neuralgia","display_name":"postherpetic neuralgia","score":1.0},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.5740000009536743},{"id":"https://openalex.org/keywords/sleep-interference","display_name":"sleep interference","score":0.8059999942779541},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.8119999766349792},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.734000027179718},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.49399998784065247},{"id":"https://openalex.org/keywords/flexible-dosing","display_name":"flexible dosing","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.9909803867340088},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.863121747970581},{"id":"https://openalex.org/C2778866549","wikidata":"https://www.wikidata.org/wiki/Q1714245","display_name":"Postherpetic neuralgia","level":3,"score":0.7871986627578735},{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.6718814969062805},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6669021844863892},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6087419390678406},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5410616993904114},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4675767719745636},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.46023038029670715},{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.43289974331855774},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3830673396587372},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32187432050704956},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009437","descriptor_name":"Neuralgia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009437","descriptor_name":"Neuralgia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015990","descriptor_name":"Placebo Effect","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016037","descriptor_name":"Single-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/ajp.0b013e3181fe13f6","doi":"https://doi.org/10.1097/ajp.0b013e3181fe13f6","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ajp.0b013e3181fe13f6","pdf_url":null,"source":{"id":"https://openalex.org/S102460418","display_name":"Clinical Journal of Pain","issn_l":"0749-8047","issn":["0749-8047","1536-5409"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Clinical Journal of Pain","raw_type":"journal-article"},{"id":"pmid:21178603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21178603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Clinical journal of pain","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1965202316","https://openalex.org/W1972387365","https://openalex.org/W1974794713","https://openalex.org/W1988452935","https://openalex.org/W1994334998","https://openalex.org/W1995051534","https://openalex.org/W2001683083","https://openalex.org/W2007122791","https://openalex.org/W2011913908","https://openalex.org/W2014570809","https://openalex.org/W2020407769","https://openalex.org/W2026856110","https://openalex.org/W2036949225","https://openalex.org/W2047744167","https://openalex.org/W2048405347","https://openalex.org/W2053503958","https://openalex.org/W2054260401","https://openalex.org/W2055117454","https://openalex.org/W2068602147","https://openalex.org/W2070246197","https://openalex.org/W2072562212","https://openalex.org/W2076716839","https://openalex.org/W2080477042","https://openalex.org/W2085295826","https://openalex.org/W2121270079","https://openalex.org/W2124677225","https://openalex.org/W2126855798","https://openalex.org/W2152802140","https://openalex.org/W2152953447","https://openalex.org/W2159977024","https://openalex.org/W2166281097","https://openalex.org/W2418355013","https://openalex.org/W2473786944"],"related_works":["https://openalex.org/W2076716839","https://openalex.org/W2068757724","https://openalex.org/W1845521331","https://openalex.org/W2049689960","https://openalex.org/W2159977024","https://openalex.org/W2082846225","https://openalex.org/W2492052346","https://openalex.org/W2136415182","https://openalex.org/W2068602147","https://openalex.org/W2748681785"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"date,":[2],"published":[3],"neuropathic":[4,32,267],"pain":[5,33,66,113,207,268],"randomized":[6,40,71],"controlled":[7],"trials":[8],"of":[9,31,140,143,148,184,194,222,228,252,265],"pregabalin":[10,26,50,79,102,120,189,223,243,253],"have":[11],"involved":[12],"primarily":[13],"diabetic":[14],"peripheral":[15,266],"neuropathy":[16],"(DPN)":[17],"and":[18,68,72,99,122,154,169,173,176,191,224,234,236,242,259,273],"postherpetic":[19],"neuralgia":[20],"(PHN).":[21],"This":[22],"multicenter":[23],"trial":[24],"evaluated":[25],"in":[27,118,125,164,187,197,206,261],"a":[28,64,146,203,262],"broader":[29,263],"range":[30,264],"etiologies.":[34],"METHODS:":[35],"In":[36,180],"this":[37],"enriched":[38],"enrollment":[39],"withdrawal":[41],"trial,":[42],"256":[43],"patients":[44,144,238],"received":[45],"single":[46,92],"blind,":[47,75],"flexible":[48],"dose":[49],"for":[51,86],"4":[52],"weeks;":[53],"stable":[54],"concomitant":[55],"analgesics":[56],"were":[57,70,115,136,161,215],"allowed.":[58],"One":[59],"hundred":[60],"sixty-five":[61],"(65%)":[62],"had":[63,201],"\u226530%":[65],"improvement":[67],"157":[69],"treated,":[73],"double":[74],"to":[76,82,226],"either":[77,149,202],"continue":[78],"(n=80)":[80],"or":[81,151,208],"receive":[83],"placebo":[84,98,127,199,241],"(n=77)":[85],"5":[87,235],"weeks.":[88],"RESULTS:":[89],"Of":[90],"the":[91,104,108,119,126,141,188,198,210,218,231,240],"blind":[93],"responders":[94],"randomized,":[95],"81%":[96],"on":[97,101],"86%":[100],"completed":[103],"double-blind":[105,109,211],"phase.":[106,212],"At":[107],"endpoint,":[110],"mean":[111],"(SD)":[112],"scores":[114],"2.9":[116],"(1.9)":[117],"group":[121,128,190,200],"3.5":[123],"(1.7)":[124],"(P=0.002).":[129],"These":[130,247],"modest":[131],"yet":[132],"significant":[133],"pregabalin-placebo":[134],"differences":[135,160],"observed":[137,163],"within":[138],"each":[139],"subgroups":[142],"with":[145,155,217],"diagnosis":[147],"DPN":[150,272],"PHN":[152],"(P=0.03),":[153],"other":[156,177],"diagnoses":[157],"(P=0.02).":[158],"Significant":[159],"also":[162],"sleep":[165],"interference,":[166],"Hospital":[167],"Anxiety":[168,172],"Depression":[170,174],"Scale":[171],"subscales,":[175],"secondary":[178],"measures.":[179],"total,":[181],"28":[182,192],"out":[183,193],"80":[185],"(35.0%)":[186],"77":[195],"(36.4%)":[196],"meaningful":[204],"increase":[205],"discontinued":[209],"Adverse":[213],"events":[214],"consistent":[216],"known":[219],"tolerability":[220,260],"profile":[221],"led":[225],"discontinuation":[227],"9":[229],"during":[230],"single-blind":[232],"phase,":[233],"2":[237],"from":[239],"groups,":[244],"respectively.":[245],"DISCUSSION:":[246],"results":[248],"support":[249],"previous":[250],"evidence":[251],"efficacy":[254,258],"but":[255],"further":[256],"demonstrate":[257],"conditions":[269],"beyond":[270],"just":[271],"PHN.":[274]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}